The results presented here indicate that the major metabolic changes observed in HCC cells that have undergone EMT after chronic treatment with TGF-β include relevant changes in lipid turnover and an increase in lipid catabolism, which correlate with major OXPHOS capacity and a decrease in aerobic glycolysis. Here, TGFB1 is linked to hepatocellular carcinoma.